Thermo Fisher Buys Denmark's Proxeon to Build up its LC Product Line for Proteomics

Since launching its Accela HPLC line in 2006, Thermo Fisher has been largely quiet on the LC front, but according to a company official, today's acquisition "allows us to offer a more tightly integrated solution for proteomic LC/MS applications.”

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.